A client taking atorvastatin reports new diffuse muscle pain and weakness. The urine is dark, creatine kinase …

Question

A client taking atorvastatin reports new diffuse muscle pain and weakness. The urine is dark, creatine kinase is markedly elevated, and creatinine is rising. Which action should the nurse take?

Accepted Answer

Option 4: Hold atorvastatin, notify the provider, monitor renal function and electrolytes, and begin prescribed isotonic hydration.

Muscle pain and weakness with markedly elevated creatine kinase, dark urine, and rising creatinine indicate statin-associated rhabdomyolysis with risk of myoglobin-related acute kidney injury and electrolyte abnormalities. Atorvastatin is held, the provider is notified promptly, renal function and electrolytes are monitored, and prescribed isotonic hydration is initiated. Continuing the statin, delaying evaluation, or restricting fluid can worsen injury.

Answer

Option 1: Administer the scheduled atorvastatin and encourage ambulation to determine whether the weakness improves with activity.

Answer

Option 2: Give an analgesic for the muscle pain and arrange to repeat the laboratory tests at the next routine appointment.

Answer

Option 3: Restrict oral and intravenous fluids to reduce the workload on the kidneys while the creatine kinase remains elevated.

A client taking atorvastatin reports new diffuse muscle pain and weakness. The urine is dark, creatine kinase is markedly elevated, and creatinine is rising. Which action should the nurse take?

In-depth explanation

Master the NCLEX-RN with MyMerci

성장을 멈추지 마세요

A client taking atorvastatin reports new diffuse muscle pain and weakness. The urine is dark, creatine kinase is markedly elevated, and creatinine is rising. Which action should the nurse take?

In-depth explanation

Master the NCLEX-RN with MyMerci